Navigation Links
InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
Date:7/31/2008

off-label sales of Actimmune for the treatment of IPF, which InterMune does not promote. Revenue from the collaboration with Roche was $1.6 million in the first six months of 2008, compared with $11.6 million in the same period of 2007.

R&D expenses were $52.6 million in the first six months of 2008, an 8% decrease compared to $57.4 million in the same period of 2007. This decrease was primarily due to termination of the INSPIRE Phase 3 trial of Actimmune in March 2007. G&A expenses of $14.6 million in the first half of 2008 were approximately 12% lower than $16.6 million in the first six months of 2007, reflecting headcount reduction and cost-control initiatives following termination of the INSPIRE trial.

Second Quarter Highlights

Pirfenidone:

-- Shionogi & Co., Ltd of Japan, which has rights to pirfenidone in

Japan, reported results of its Phase 3 study in Japan at the

American Thoracic Society meeting in Toronto on May 20. Following

the presentation, InterMune noted the following:

-- The baseline characteristics of patients enrolled in the

Shionogi Phase 3 trial and the InterMune Phase 3 CAPACITY

program are extremely similar.

-- The Shionogi Phase 3 trial confirmed the results reported by

Shionogi from their Phase 2 trial; notably a positive effect of

pirfenidone on the rate of decline in Vital Capacity over time

and an acceptable safety profile.

-- The number of patient dropouts in the Shionogi study was

consistent with that of other multi-center studies of other

compounds in IPF and the nature of the dropouts in the Shionogi

study may have underestimated the treatment effect of

pirfenidone.

-- The study conduct of CAPACITY is excellent and InterMune

expects to achiev
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... (PRWEB) August 20, 2014 Not long ... E&L studies should be performed late in the development ... known. But current regulatory trends suggest that, like many ... the rise. In recent years, multiple drug sponsors have ... or address specific questions during phase I/II. It’s not ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic Patient ... its myPROpad™ ePRO tablet with the addition of a ... most widely used and well-respected Patient Reported Outcome (PRO) ... is used during clinical trials and in other health ... used to demonstrate Health-Related Quality of Life outcomes (HRQoL) ...
(Date:8/19/2014)... Md. (PRWEB) August 19, 2014 ... liquid chromatography systems, Prominence-i and Nexera-i, adding to ... systems. Combining excellent functionality, an intuitive operating environment, ... and a more efficient workflow for conventional to ... feature innovative, intuitive and intelligent design so users ...
(Date:8/19/2014)... IRVINE, Calif. (PRWEB) August 19, 2014 ... Indiegogo campaign to raise $200,000 to fund a ... diagnostic device. , This development is a ... one-size-fits-all model of care to the implementation of ... patient-centric method of practicing medicine. , Indiegogo contributions ...
Breaking Biology Technology:Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2EQ-5D™ Assessment Now Available for iPad 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3
... needed for the Information Age. Their administrations, as well as ... beyond the Industrial Age. , ,For the most part, ... talking about reading, writing and `rithmetic; I am talking about ... regimentation, which is what was needed to assimilate people into ...
... Wis. - Global Renewable LLC, a Whitewater, Wis. partnership ... plans to build and operate a $195 million ethanol plant ... ,Pending municipal approvals, the Sharon Ethanol Plant annually would produce ... create an estimated 55 new full-time jobs and more than ...
... Madison, Wis. - TrafficCast International , a ... occur, and generates rerouting instructions for digital navigation services, ... ,Part of the reason is that it has cut ... road systems in the world, starting with those of ...
Cached Biology Technology:Rote education fails the Information Age 2Rote education fails the Information Age 3Rote education fails the Information Age 4Traffic data firm navigates international business 2
(Date:8/20/2014)... Calif., August 19, 2014 -- Bay Area Lyme Foundation, ... and simple to cure, applauds new research published in ... Ticks and Tick-borne Diseases . The findings ... California are active throughout the year, making the threat ... researchers at California Department of Public Health (CDPH) Vector-borne ...
(Date:8/20/2014)... suffered concussions ready to return to action? A new ... athletes who head back on the field with medical ... their abilities to simultaneously walk and do simple mental ... their balance and/or altered walking speed, was found in ... returned to activity in less than a month. Seven ...
(Date:8/20/2014)... years, Virginia Tech,s Wu Feng has built upon a ... "Computing in the Cloud" program, and synergistically complemented it ... from the Air Force on "big computing" for mini-drones ... National Institutes of Health on "big data" for the ... computing" aspects from each grant, he was able to ...
Breaking Biology News(10 mins):Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4
... of Neurosciences at Universitat Autnoma de Barcelona (INc-UAB) identified ... neuron survival associated with synaptic activity. The discovery, published ... scientists to study a new target that could help ... which are known to cause early cognitive deficit, and ...
... team of researchers led by Boston University School of ... be associated with decreasing the volume of the hippocampus. ... plays an important role in the formation of specific, ... Alzheimer,s disease lose. The findings may have broad implications ...
... ,A new study using satellite mapping technology reveals there are ... thought. The results provide an important benchmark for monitoring the ... bird. Reporting this week in the journal PLoS ... used Very High Resolution (VHR) satellite images to estimate the ...
Cached Biology News:Researchers have identified a gene with a key role in neuronal survival 2BUSM researchers identify genes that influence hippocampal volume 2Scientists count penguins from space 2
... Although there have been many modifications to the ... media, salt solutions still play an important role ... maintain the pH and osmotic balance in the ... and essential inorganic ions, is as valuable today ...
... and Cost effective - Utilizes hands-off homogenization through ... No grinding - Extract DNA without hand ... between samples , Robust tubes - ... homogenize without tube breakage , Flexible ...
A substrate for all AChE-based EIA kits....
... The LXQ linear ion trap mass spectrometer ... analytical laboratory., The LXQ linear ion trap ... and proteomic applications, delivering the fast cycle ... linear ion trap at an attractive price. ...
Biology Products: